>
>
Postpartum Depression Treatment Market Size – By Type, By Treatment, By Route of Administration, By Distribution Channel, Global Forecast, 2025 – 2034
Download Free PDF

Postpartum Depression Treatment Market
Get a free sample of this reportGet a free sample of this report Postpartum Depression Treatment Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2024
Companies covered: 10
Tables & Figures: 123
Countries covered: 19
Pages: 130
Download Free PDF
Postpartum Depression Treatment Market Size
The global postpartum depression treatment market size was valued at USD 1 billion in 2024 and is estimated to grow at a CAGR of 9.2% from 2025 to 2034. The demand is largely attributed to the growing global focus on mental well-being among women during childcare.
There is also an increasing burden of PPD, especially among mothers, which has increased the need for better postpartum depression treatment. The introduction of brexanolone (Zulresso) has, in many ways, increased the options available, which also lets clinicians address the more complicated sides of the disorder. Global improvements in healthcare and the aforementioned factors are anticipated to accelerate the growth rate of the industry in the future.
The growing knowledge and awareness of maternal mental health is another core driver. Improved conversations on the postpartum stage are a result of public health approaches and the engagement and screening of the condition in postnatal care practices, which encourages women to show up for care. All these factors placed together present this kind of market with possibilities of growing robustly.
Mood disorder is what postpartum depression falls under, as it is a type of stress affecting women immediately after giving birth. Accountability, bonding with the baby, a feeling of dread and fatigue, anxiety, and irritability are all symptoms associated with postpartum depression. It may affect mother-infant attachment and day-to-day activity, and in extreme circumstances, it may endanger both mother and baby. In many ways, postpartum depression can be treated. It’s aimed at meeting emotional, hormonal, and physical needs so as to facilitate the recovery of mothers. This treatment includes the use of antidepressants and hormones.
Postpartum Depression Treatment Market Trends
One reason that is likely to contribute to the advancement of the industry dealing with the treatment of postpartum depression is the growing prevalence of the disease.
Postpartum Depression Treatment Market Analysis
Based on the type, the market is segmented into postpartum anxiety, postpartum blues, postpartum post-traumatic stress disorder (PTSD), postpartum obsessive-compulsive disorder (OCD), postpartum panic disorder, and postpartum psychosis. The postpartum anxiety segment dominated the market with a 23.5% share in 2024.
Based on the treatment, the postpartum depression treatment market is categorized into pharmacotherapy, hormone therapy, and other treatments. The pharmacotherapy segment is further sub-categorized into selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCA), and other pharmacotherapies. The pharmacotherapy segment was valued at USD 549.8 million in 2024 and is poised to grow at 9.1% CAGR.
Based on the route of administration, the postpartum depression treatment market is divided into oral, parenteral, and other routes of administration. The oral segment accounted for the highest market share and is expected to reach USD 1.5 billion by the end of the analysis period.
Based on the distribution channel, the postpartum depression treatment market is classified into hospital pharmacies, retail pharmacies, and online pharmacies. In 2024, the hospital pharmacies segment held 47.2% of market share.
In 2024, the U.S. postpartum depression therapeutic market was valued at USD 370.7 million and for the forthcoming years it is expected to grow at 8.9% CAGR.
Germany postpartum depression treatment market is expected to experience significant growth.
India postpartum depression treatment market is anticipated to witness high growth during the forecast period.
Brazil postpartum depression treatment market is predicted to sharpen during the analysis phase.
The market of postpartum depression treatment in Saudi Arabia is very likely to be on the rise in the upcoming years.
Postpartum Depression Treatment Market Share
The postpartum depression treatment space has a number of players competing for market share by offering new therapies and forming partnerships. Sage Therapeutics, Biogen, Pfizer, and GSK are already capturing a portion of this market due to their strong research and development focus and the development of new pharmacological therapies. The formation of strategic partnerships, mergers, and acquisitions are normal as companies look to grow their geographic presence and improve their product base.
Postpartum Depression Treatment Market Companies
Few of the prominent players operating in the postpartum depression treatment industry include:
USPs for top players:
Postpartum Depression Treatment Industry News
The postpartum depression treatment market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Treatment
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries: